Sign In
Buy RPTX
$2.65
+0 (+0%)
At Close: Apr 24, 2026
Repare Therapeutics (NASDAQ:RPTX) Trading Up 0.8% – What’s Next?
04:48am, Friday, 20'th Feb 2026
Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report)'s stock price rose 0.8% on Thursday. The company traded as high as $2.65 and last traded at $2.65. Approximately 1,219,900 shares were traded
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
04:58pm, Friday, 16'th Jan 2026
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that its Shareho
Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4% – Here’s Why
02:27am, Thursday, 15'th Jan 2026
Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report)'s stock price rose 0.4% on Wednesday. The stock traded as high as $2.61 and last traded at $2.60. Approximately 426,036 shares changed hands d
Repare Therapeutics Target of Unusually Large Options Trading (NASDAQ:RPTX)
01:44am, Thursday, 25'th Dec 2025
Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report) was the recipient of unusually large options trading on Wednesday. Investors acquired 3,187 call options on the company. This is an increase o
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
07:00am, Wednesday, 24'th Dec 2025
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive ass
Halper Sadeh LLC Encourages UBFO, CWBC, RPTX Shareholders to Contact the Firm to Discuss Their Rights
06:12pm, Thursday, 18'th Dec 2025
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
BALA CYNWYD, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—RPTX, CNBN, KMB, and KVUE
11:18am, Thursday, 04'th Dec 2025
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights
12:39pm, Friday, 28'th Nov 2025
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights
06:47pm, Thursday, 27'th Nov 2025
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives $3.50 Average PT from Brokerages
03:28am, Tuesday, 25'th Nov 2025
Repare Therapeutics Inc. (NASDAQ: RPTX - Get Free Report) has received a consensus recommendation of "Hold" from the seven analysts that are covering the stock, Marketbeat.com reports. One research an
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that following t
Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights
07:44am, Tuesday, 18'th Nov 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights Shareholders should contact the firm immediately as there may be limited time to enforce your right
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Repare Therapeutics Inc. (NASDAQ: RPTX)
05:30pm, Monday, 17'th Nov 2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholder
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value
10:24am, Monday, 17'th Nov 2025
XenoTherapeutics Inc. and Xeno Acquisition Corp, a non-profit biotechnology company, on Friday agreed to acquire Repare Therapeutics Inc. (NASDAQ: RPTX).
